Cambridge Investment Research Advisors
CCRN

Cambridge Investment Research Advisors’s Cross Country Healthcare CCRN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,463
Closed -$71K – 2530
2020
Q2 		$71K Buy
+11,463
New +$70.3K ﹤0.01% 2355
2019
Q2 		– Sell
-85,270
Closed -$599K – 2221
2019
Q1 		$599K Buy
+85,270
New +$731K 0.01% 1362

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Cambridge Investment Research Advisors's CCRN Position: Q3 2020 in Review

Cambridge Investment Research Advisors sold out of Cross Country Healthcare (CCRN) in Q3 2020, closing a stake of 11,463 shares — an estimated $71K sold.

Cambridge Investment Research Advisors first reported a position in CCRN in Q1 2019 and held it in 2 quarters. The position peaked at $599K in Q1 2019. 118 funds tracked by Wall St. Rank hold CCRN as of Q3 2020.

  • Cambridge Investment Research Advisors reported no remaining Cross Country Healthcare position as of Q3 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,463 Cross Country Healthcare shares in Q3 2020, an estimated $71K.
  • Cambridge Investment Research Advisors first reported a position in Cross Country Healthcare in Q1 2019 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Cross Country Healthcare position peaked at $599K in Q1 2019.
  • 118 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.